Niowave, Lansing, Mich., will get $13 million from the National Nuclear Security Administration, under a cooperative agreement, to support  domestic production of the Molybdenum-99 medical isotope, the agency announced Dec. 3.
This is the fourth and final round…                    
                    
                    
                                        
                    
                
                    Nuclear Security & Deterrence Monitor Vol. 25 No. 47
Visit Archives | Return to Issue PDF
            
            
            Visit Archives | Return to Issue PDF
                Nuclear Security & Deterrence Monitor
            
            
        Article 7 of 7
             December 09, 2021
            Michigan Company Wins Mo-99 Award From NNSA
        Partner Content